Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 1:45 AM
Ignite Modification Date:
2025-12-25 @ 1:45 AM
NCT ID:
NCT00797394
Eligibility Criteria:
Inclusion Criteria:
* Patient must be an adult man aged between 50 and 75
* Patient must have Benign Prostatic Hyperplasia symptoms
Exclusion Criteria:
* Patient has a malfunction of the urinary tract, is suffering from acute urinary retention, or is suffering from prostate cancer or urinary tract infection
* Patient has been subjected to surgery of the prostate, bladder or urethra
* Patient has taken a 5-alpha-reductase inhibitor in the 6-month period preceding screening
* Patient has taken an alpha-blocker in the 2-week period preceding screening
Healthy Volunteers:
False
Sex:
MALE
Minimum Age:
50 Years
Maximum Age:
75 Years
Study:
NCT00797394
Study Brief:
Protocol Section:
NCT00797394